Search PDMR transactions

Notifier
Name of person with notification obligation
Lars Rasmussen
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Lars Rasmussen
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Coegin Pharma AB
Issuer´s LEI code
5493009LSTR50H3Y9T98
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Subcription warrant Coegin Pharma TO3 SE0021513660 Acquisition 38,461 Quantity 0.00 SEK 28/09/2024 Outside a trading venue
Share Coegin Pharma AB aktie SE0020357754 Exercise increase 38,461 Quantity 3.90 SEK 28/09/2024 Outside a trading venue
Subcription warrant Coegin Pharma TO3 SE0021513660 Exercise decrease 38,461 Quantity 0.00 SEK 28/09/2024 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Coegin Pharma TO3 SE0021513660 Acquisition 28/09/2024 Outside a trading venue 38,461 (Quantity) 0.00 SEK
Coegin Pharma AB aktie SE0020357754 Exercise increase 28/09/2024 Outside a trading venue 38,461 (Quantity) 3.90 SEK
Coegin Pharma TO3 SE0021513660 Exercise decrease 28/09/2024 Outside a trading venue 38,461 (Quantity) 0.00 SEK
<< Back